All In Biotech

Free tool

FAERS Monitor: Coreg Cr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022012 or its brand name (Coreg Cr, Carvedilol Phosphate). Reports on generic versions are filed under their own applications.

Reports

2,975

Serious

1,127

38% of reports

Hospitalization

590

Death reported

148

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dizziness309
  • fatigue298
  • drug ineffective291
  • dyspnoea192
  • nausea145
  • headache142
  • blood pressure increased139
  • diarrhoea131
  • hypotension121
  • asthenia109
  • malaise104
  • fall92
  • weight increased85
  • death76
  • feeling abnormal75

Reports by year received

View as table
YearReports
2007499
2008443
2009305
2010155
2011162
2012126
2013145
2014210
2015196
2016162
2017124
2018100
2019112
202067
202134
202232
202319
202430
202534
202620

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,184 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood pressure increasedSignal1396.45.5636
dizzinessSignal3094.43.9822
hypotensionSignal1214.33.6302
fatigueSignal2982.72.4331
weight increasedSignal852.72.289
dyspnoeaSignal1922.42.1159
feeling abnormalSignal752.21.849
astheniaSignal1092.01.759
fall922.01.643
malaise1041.71.428
headache1421.61.432
drug ineffective2911.61.462
diarrhoea1311.41.217
nausea1451.31.110
death760.60.518

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.